a 2020

Ponatinib Treatment in CML and Ph+ all patients: real-life data from the Czech registries.

KORIŤÁKOVÁ, E., Michael DOUBEK, E. FABER, T. SZOTKOWSKI, E. CMUNT et. al.

Basic information

Original name

Ponatinib Treatment in CML and Ph+ all patients: real-life data from the Czech registries.

Authors

KORIŤÁKOVÁ, E., Michael DOUBEK, E. FABER, T. SZOTKOWSKI, E. CMUNT, J. HORÁČEK, P. BĚLOHLÁVKOVÁ, P. JINDRA, L. STEJSKAL, Z. KOŘÍSTEK, H. KLAMOVÁ, C. ŠÁLEK, František FOLBER, R. KELLNEROVÁ, M. CHRÁPAVÁ and Daniela ŽÁČKOVÁ

Edition

Pražské hematologické dny, Praha, sb. abstrakt, s.130-1, 2020

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Faculty of Medicine
Changed: 10/2/2021 11:30, Jitka Firešová